{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:19:17Z","timestamp":1788538757098,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03538-9","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:46:16Z","timestamp":1788536776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Formulation, Optimization and Characterization of Acetazolamide-Loaded Solid Lipid Nanoparticles for Glaucoma Treatment: In-Vitro and In-Vivo Study"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-3043","authenticated-orcid":false,"given":"Shuchi","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5344-900X","authenticated-orcid":false,"family":"Ankur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3779-5455","authenticated-orcid":false,"family":"Garima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-3807","authenticated-orcid":false,"given":"Rajan","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3334-1712","authenticated-orcid":false,"given":"Neeraj","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"3538_CR1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1039\/D5PM00068H","volume":"2","author":"S Kundu","year":"2025","unstructured":"Kundu S, Kumari G, Srinivasarao DA. Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharm. 2025;2:1050\u201377.","journal-title":"RSC Pharm"},{"key":"3538_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","volume":"354","author":"AL Onugwu","year":"2023","unstructured":"Onugwu AL, Nwagwu CS, Onugwu OS, et al. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. J Control Release. 2023;354:465\u201388.","journal-title":"J Control Release"},{"key":"3538_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247651","author":"B Mahaling","year":"2024","unstructured":"Mahaling B, Baruah N, Dinabandhu A. Nanomedicine in ophthalmology: from bench to bedside. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13247651.","journal-title":"J Clin Med"},{"key":"3538_CR4","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.2147\/IJN.S532074","volume":"20","author":"X Lin","year":"2025","unstructured":"Lin X, Zhou Y, Lv K, et al. Nanomedicine-based ophthalmic drug delivery systems for the treatment of ocular diseases. Int J Nanomedicine. 2025;20:9221.","journal-title":"Int J Nanomedicine"},{"key":"3538_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40135-025-00332-x","volume":"13","author":"S Hallaj","year":"2025","unstructured":"Hallaj S, Shalaby WS, Sinha S, et al. Systemic carbonic anhydrase inhibitors in common ophthalmic diseases: a scoping review from a clinical standpoint. Curr Ophthalmol Rep. 2025;13:9.","journal-title":"Curr Ophthalmol Rep"},{"key":"3538_CR6","doi-asserted-by":"publisher","first-page":"9977938","DOI":"10.1155\/jnt\/9977938","volume":"2025","author":"A Kishore","year":"2025","unstructured":"Kishore A, Mahor AK, Gupta R, et al. Acetazolamide-Loaded Poly(\u03b4-Decalactone) Nanoemulsion for Topical Eye Delivery: Enhanced Corneal Permeation and Sustained Intraocular Pressure Reduction in Glaucoma Therapy. J Nanotechnol. 2025;2025:9977938.","journal-title":"J Nanotechnol"},{"key":"3538_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040191","author":"V Mishra","year":"2018","unstructured":"Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10040191.","journal-title":"Pharmaceutics"},{"key":"3538_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104709","volume":"86","author":"M Akanda","year":"2023","unstructured":"Akanda M, Mithu MSH, Douroumis D. Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment. J Drug Deliv Sci Technol. 2023;86:104709.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3538_CR9","doi-asserted-by":"publisher","first-page":"7299","DOI":"10.1007\/s11696-025-04315-x","volume":"79","author":"S Khaledian","year":"2025","unstructured":"Khaledian S, Abdoli M, Mirzaee S, et al. Nanostructure colloids in ocular drug delivery: advances and challenges. Chem Pap. 2025;79:7299\u2013322.","journal-title":"Chem Pap"},{"key":"3538_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","volume":"24","author":"I Singh","year":"2016","unstructured":"Singh I, Swami R, Pooja D, et al. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 2016;24:212\u201323.","journal-title":"J Drug Target"},{"key":"3538_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106494","volume":"187","author":"Z Liang","year":"2023","unstructured":"Liang Z, Zhang Z, Lu P, et al. The effect of charges on the corneal penetration of solid lipid nanoparticles loaded econazole after topical administration in rabbits. Eur J Pharm Sci. 2023;187:106494.","journal-title":"Eur J Pharm Sci"},{"key":"3538_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101910","volume":"59","author":"AM Mohsen","year":"2020","unstructured":"Mohsen AM, Salama A, Kassem AA. Development of acetazolamide loaded bilosomes for improved ocular delivery: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol. 2020;59:101910.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3538_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/08982104.2020.1748648","volume":"31","author":"T Waghule","year":"2021","unstructured":"Waghule T, Rapalli VK, Singhvi G, et al. Design of temozolomide-loaded proliposomes and lipid crystal nanoparticles with industrial feasible approaches: comparative assessment of drug loading, entrapment efficiency, and stability at plasma pH. J Liposome Res. 2021;31:158\u201368.","journal-title":"J Liposome Res"},{"key":"3538_CR14","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.2147\/IJN.S201891","volume":"14","author":"RS Abdel-Rashid","year":"2019","unstructured":"Abdel-Rashid RS, Helal DA, Omar MM, et al. Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide. Int J Nanomedicine. 2019;14:2973\u201383.","journal-title":"Int J Nanomedicine"},{"key":"3538_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103780","volume":"76","author":"B Das","year":"2022","unstructured":"Das B, Nayak AK, Mallick S. Lipid-based nanocarriers for ocular drug delivery: an updated review. J Drug Deliv Sci Technol. 2022;76:103780.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3538_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm-2018-0278","volume":"14","author":"M Singh","year":"2019","unstructured":"Singh M, Guzman-Aranguez A, Hussain A, et al. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics. Nanomedicine (Lond). 2019;14:465\u201391.","journal-title":"Nanomedicine (Lond)"},{"key":"3538_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020221","author":"R Abdelmonem","year":"2021","unstructured":"Abdelmonem R, Elhabal SF, Abdelmalak NS, et al. Formulation and characterization of acetazolamide\/carvedilol niosomal gel for glaucoma treatment: in vitro, and in vivo study. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020221.","journal-title":"Pharmaceutics"},{"key":"3538_CR18","first-page":"1","volume":"13","author":"M Morais","year":"2021","unstructured":"Morais M, Coimbra P, Pina ME. Comparative Analysis of Morphological and Release Profiles in Ocular Implants of Acetazolamide Prepared by Electrospinning. Pharm. 2021;13:1\u201314.","journal-title":"Pharm."},{"key":"3538_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/10717544.2021.1872740","volume":"28","author":"S Sayed","year":"2021","unstructured":"Sayed S, Abdel-Moteleb M, Amin MM, et al. Cubogel as potential platform for glaucoma management. Drug Deliv. 2021;28:293.","journal-title":"Drug Deliv"},{"key":"3538_CR20","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms24032914","volume":"24","author":"IP S\u00e6b\u00f8","year":"2023","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, et al. Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity. Int J Mol Sci. 2023;24:2914.","journal-title":"Int J Mol Sci"},{"key":"3538_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123746","volume":"650","author":"US Bagul","year":"2024","unstructured":"Bagul US, Nazirkar MV, Mane AK, et al. Fabrication of architectonic nanosponges for intraocular delivery of brinzolamide: an insight into QbD driven optimization, in vitro characterization, and pharmacodynamics. Int J Pharm. 2024;650:123746.","journal-title":"Int J Pharm"},{"key":"3538_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125507","volume":"674","author":"PHR da Silva","year":"2025","unstructured":"da Silva PHR, de Castro MA, Ribeiro MCS, et al. Acetazolamide-loaded intravitreal implants for the treatment of glaucoma: formulation, physicochemical characterization and assessment of in vitro and in vivo safety. Int J Pharm. 2025;674:125507.","journal-title":"Int J Pharm"},{"key":"3538_CR23","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02459-7","author":"LM Abd El Wahab","year":"2022","unstructured":"Abd El Wahab LM, Essa EA, El Maghraby GM, et al. The development and evaluation of phase transition microemulsion for ocular delivery of acetazolamide for glaucoma treatment. AAPS PharmSciTech. 2022. https:\/\/doi.org\/10.1208\/s12249-022-02459-7.","journal-title":"AAPS PharmSciTech"},{"key":"3538_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01715-20","volume":"65","author":"NS Abutaleb","year":"2021","unstructured":"Abutaleb NS, Elkashif A, Flaherty DP, et al. In vivo antibacterial activity of acetazolamide. Antimicrob Agents Chemother. 2021;65:e01715-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"3538_CR25","doi-asserted-by":"publisher","DOI":"10.1017\/S0022149X23000731","author":"EF Abdel Hamed","year":"2023","unstructured":"Abdel Hamed EF, Taha AA, Abdel Ghany SM, et al. Acetazolamide loaded-silver nanoparticles: a potential treatment for murine trichinellosis. J Helminthol. 2023. https:\/\/doi.org\/10.1017\/S0022149X23000731.","journal-title":"J Helminthol"},{"key":"3538_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/fcp.13032","volume":"38","author":"YM Tamim","year":"2024","unstructured":"Tamim YM, Soliman ML, Sayed MM, et al. Acetazolamide suppresses the progression of hepatocellular carcinoma induced by diethylnitrosamine in Wistar albino rats. Fundam Clin Pharmacol. 2024;38:1045\u201358.","journal-title":"Fundam Clin Pharmacol"},{"key":"3538_CR27","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s13346-020-00856-8","volume":"11","author":"AH Salama","year":"2021","unstructured":"Salama AH, AbouSamra MM, Awad GEA, et al. Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation. Drug Deliv Transl Res. 2021;11:1943\u201357.","journal-title":"Drug Deliv Transl Res"},{"key":"3538_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2147\/IJN.S196771","volume":"14","author":"R Albash","year":"2019","unstructured":"Albash R, Abdelbary AA, Refai H, et al. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J Nanomedicine. 2019;14:1953\u201368.","journal-title":"Int J Nanomedicine"},{"key":"3538_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105454","author":"NS Abutaleb","year":"2022","unstructured":"Abutaleb NS, Elhassanny AEM, Seleem MN. In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection. Microb Pathog. 2022. https:\/\/doi.org\/10.1016\/j.micpath.2022.105454.","journal-title":"Microb Pathog"},{"key":"3538_CR30","doi-asserted-by":"publisher","DOI":"10.1148\/RADIOL.221473","author":"S Dogra","year":"2023","unstructured":"Dogra S, Wang X, Gupta A, et al. Acetazolamide-augmented BOLD MRI to assess whole-brain cerebrovascular reactivity in chronic steno-occlusive disease using principal component analysis. Radiology. 2023. https:\/\/doi.org\/10.1148\/RADIOL.221473.","journal-title":"Radiology"},{"key":"3538_CR31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.talanta.2008.05.019","volume":"76","author":"MA Bezerra","year":"2008","unstructured":"Bezerra MA, Santelli RE, Oliveira EP, et al. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 2008;76:965\u201377.","journal-title":"Talanta"},{"key":"3538_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.22270\/jddt.v12i1.5154","volume":"12","author":"A Sheikh","year":"2022","unstructured":"Sheikh A, Asati S. Preparation, evaluation and optimization of solid lipid nanoparticles composed of pantoprazole. J Drug Deliv Ther. 2022;12:12\u20138.","journal-title":"J Drug Deliv Ther"},{"key":"3538_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040447","author":"FM Gonz\u00e1lez-Fern\u00e1ndez","year":"2021","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez FM, Bianchera A, Gasco P, et al. Lipid-based nanocarriers for ophthalmic administration: towards experimental design implementation. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040447.","journal-title":"Pharmaceutics"},{"key":"3538_CR34","first-page":"1926","volume":"46","author":"MU Rehman","year":"2018","unstructured":"Rehman MU, Khan MA, Khan WS, et al. Fabrication of niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018;46:1926\u201334.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3538_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.123195","volume":"240","author":"D Elfadil","year":"2022","unstructured":"Elfadil D, Palmieri S, Della Pelle F, et al. Enzyme inhibition coupled to molecularly imprinted polymers for acetazolamide determination in biological samples. Talanta. 2022;240:123195.","journal-title":"Talanta"},{"key":"3538_CR36","first-page":"108","volume":"11","author":"N Joshi","year":"2021","unstructured":"Joshi N, Juyal V, Arya RKK, et al. Development and characterization of acetazolamide nanoemulsion for effective ocular delivery. Int J Life Sci Pharma Res. 2021;11:108\u201321.","journal-title":"Int J Life Sci Pharma Res"},{"key":"3538_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124098","author":"R Vallejo","year":"2024","unstructured":"Vallejo R, Quinteros D, Guti\u00e9rrez J, et al. Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment. Int J Pharm. 2024. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124098.","journal-title":"Int J Pharm"},{"key":"3538_CR38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022;387:1185\u201395.","journal-title":"N Engl J Med"},{"key":"3538_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2291336","author":"D Tsikas","year":"2024","unstructured":"Tsikas D. Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship. J Enzyme Inhib Med Chem. 2024. https:\/\/doi.org\/10.1080\/14756366.2023.2291336.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3538_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"CT Supuran","year":"2021","unstructured":"Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond). 2021;135:1233\u201349.","journal-title":"Clin Sci (Lond)"},{"key":"3538_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/14756366.2018.1547288","volume":"34","author":"S Ser\u0161en","year":"2019","unstructured":"Ser\u0161en S, Traven K, Kljun J, et al. Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII. J Enzyme Inhib Med Chem. 2019;34:388\u201393.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3538_CR42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","volume":"7","author":"CS Hewitt","year":"2021","unstructured":"Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis. 2021;7:1969\u201384.","journal-title":"ACS Infect Dis"},{"key":"3538_CR43","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/acba9d","author":"N U\u011furlu","year":"2023","unstructured":"U\u011furlu N, Erdal E, Malekghasemi S, et al. Effectiveness of carbonic anhydrase inhibitor loaded nanoparticles in the treatment of diabetic retinopathy. Biomed Phys Eng Express. 2023. https:\/\/doi.org\/10.1088\/2057-1976\/acba9d.","journal-title":"Biomed Phys Eng Express"},{"key":"3538_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122537","author":"WM Eldehna","year":"2023","unstructured":"Eldehna WM, El Hassab MA, Abdelshafi NA, et al. Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors. Int J Pharm. 2023. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122537.","journal-title":"Int J Pharm"},{"key":"3538_CR45","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02617-5","author":"VS Nair","year":"2023","unstructured":"Nair VS, Srivastava V, Bhavana V, et al. Exploring penetration ability of carbonic anhydrase inhibitor-loaded ultradeformable bilosome for effective ocular application. AAPS PharmSciTech. 2023. https:\/\/doi.org\/10.1208\/s12249-023-02617-5.","journal-title":"AAPS PharmSciTech"},{"key":"3538_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/17425255.2024.2328152","volume":"20","author":"CT Supuran","year":"2024","unstructured":"Supuran CT. Drug interactions of carbonic anhydrase inhibitors and activators. Expert Opin Drug Metab Toxicol. 2024;20:143\u201355.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3538_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25102362","author":"K Tatiparti","year":"2020","unstructured":"Tatiparti K, Rauf MA, Sau S, et al. Carbonic anhydrase-IX guided albumin nanoparticles for hypoxia-mediated triple-negative breast cancer cell killing and imaging of patient-derived tumor. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25102362.","journal-title":"Molecules"},{"key":"3538_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104908","volume":"26","author":"V Verdoliva","year":"2025","unstructured":"Verdoliva V, De Luca V, Supuran CT, et al. Acetazolamide-loaded nanoparticle based on modified hyaluronic acid as delivery system to target carbonic anhydrases in Escherichia coli. Int J Mol Sci. 2025;26:4908.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3538_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pharmaceutics14010090","volume":"14","author":"L Bonilla","year":"2022","unstructured":"Bonilla L, Espina M, Severino P, et al. Lipid Nanoparticles for the Posterior Eye Segment. Pharm. 2022;14(1):90. https:\/\/doi.org\/10.3390\/pharmaceutics14010090.","journal-title":"Pharm"},{"key":"3538_CR50","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00204-022-03289-z","volume":"96","author":"FP Busard\u00f2","year":"2022","unstructured":"Busard\u00f2 FP, Lo Faro AF, Sirignano A, et al. In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common \u2018diuretic and masking agent\u2019 in doping. Arch Toxicol. 2022;96:1989\u20132001.","journal-title":"Arch Toxicol"},{"key":"3538_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103327","volume":"71","author":"P Chaudhari","year":"2022","unstructured":"Chaudhari P, Shetty D, Lewis SA. Recent progress in colloidal nanocarriers loaded in situ gel in ocular therapeutics. J Drug Deliv Sci Technol. 2022;71:103327.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3538_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413405","author":"S Kalinin","year":"2021","unstructured":"Kalinin S, Malkova A, Sharonova T, et al. Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413405.","journal-title":"Int J Mol Sci"},{"key":"3538_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.slast.2022.09.005","volume":"27","author":"C Dierks","year":"2022","unstructured":"Dierks C, S\u00f6ldner R, Pr\u00fchl K, et al. Towards an automated approach for smart sterility test examination. SLAS Technol. 2022;27:339\u201343.","journal-title":"SLAS Technol"},{"key":"3538_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2024.05.031","volume":"371","author":"B Ahmed","year":"2024","unstructured":"Ahmed B, Jaiswal S, Naryal S, et al. In situ gelling systems for ocular drug delivery. J Control Release. 2024;371:67\u201384.","journal-title":"J Control Release"},{"key":"3538_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.850757","author":"MS Razavi","year":"2022","unstructured":"Razavi MS, Ebrahimnejad P, Fatahi Y, et al. Recent developments of nanostructures for the ocular delivery of natural compounds. Front Chem. 2022. https:\/\/doi.org\/10.3389\/fchem.2022.850757.","journal-title":"Front Chem"},{"key":"3538_CR56","unstructured":"OECD\/OCDE 404 OECD Guideline for the testing of chemicals acute dermal irritation\/corrosion."},{"key":"3538_CR57","unstructured":"OECD\/OCDE 405 OECD Guideline for the testing of chemicals acute dermal irritation\/corrosion."},{"key":"3538_CR58","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","volume":"82","author":"JH Draize","year":"1944","unstructured":"Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"3538_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050465","author":"EA Mazyed","year":"2020","unstructured":"Mazyed EA, Abdelaziz AE. Fabrication of transgelosomes for enhancing the ocular delivery of acetazolamide: statistical optimization, in vitro characterization, and in vivo study. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12050465.","journal-title":"Pharmaceutics"},{"key":"3538_CR60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/futurepharmacol4020022","volume":"4","author":"S Virani","year":"2024","unstructured":"Virani S, Rewri P. A Narrative Review of Pharmacotherapy of Glaucoma. Futur Pharmacol. 2024;4:395\u2013419.","journal-title":"Futur Pharmacol."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03538-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:46:17Z","timestamp":1788536777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03538-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"265"}}